Nom du produit:6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

IUPAC Name:6-bromo-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione

CAS:4956-05-2
Formule moléculaire:C3H2BrN3O2
Pureté:96%
Numéro de catalogue:CM253184
Poids moléculaire:191.97

Unité d'emballage Stock disponible Prix($) Quantité
CM253184-25g in stock NJư
CM253184-100g in stock ȺŵNJ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:4956-05-2
Formule moléculaire:C3H2BrN3O2
Point de fusion:-
Code SMILES:O=C(N1)NN=C(Br)C1=O
Densité:
Numéro de catalogue:CM253184
Poids moléculaire:191.97
Point d'ébullition:
N° Mdl:MFCD00154757
Stockage:Keep in inert atmosphere, store at 2-8°C.

Category Infos

Triazines
Triazines are an important class of six-membered aromatic heterocycles with three nitrogen atoms that give rise to three regioisomers: 1,2,4-triazines, 1,2,3-triazines, and 1,3, 5-triazine. 1,2,3-Triazines show remarkable reactivity and have attracted attention for their medicinal value. Triazine compounds fused with other carbon and heterocycles are stable and have a broad spectrum of pharmacological activities.

Column Infos

ALG-055009
Aligos Therapeutics announced positive topline results from the Phase 2a HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction associated steatohepatitis (MASH) subjects. ALG-055009 demonstrated a favorable tolerability profile with no serious adverse events (SAEs), or clinical hyper/hypothyroidism. The majority of treatment emergent adverse events (TEAEs) were mild to moderate, with one discontinuation due to worsening insomnia in a subject with pre-existing insomnia.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.